Table 6.
Clinically significant changes in outcome measures at postintervention (n=22) and 1-month follow-up (n=21) evaluations.
| Outcome measure | Postintervention (n=22) | One-month follow-up (n=21) | |
| Gambling symptom severity (G-SASa), n (%) | |||
|
|
Recoveredb | 6 (27) | 6 (28) |
|
|
Improved | 2 (9) | 4 (19) |
|
|
Unchanged | 13 (59) | 11 (52) |
|
|
Deteriorated | 1 (4) | 0 (0) |
| Gambling cravings (G-SAS Urge Subscale), n (%) | |||
|
|
Recovered | 6 (27) | 7 (33) |
|
|
Improved | 0 (0) | 0 (0) |
|
|
Unchanged | 14 (63) | 14 (66) |
|
|
Deteriorated | 2 (9) | 0 (0) |
| Total gambling frequencyc (days), n (%) | |||
|
|
Recovered | 2 (9) | 2 (10) |
|
|
Improved | 0 (0) | 0 (0) |
|
|
Unchanged | 20 (90) | 18 (90) |
|
|
Deteriorated | 0 (0) | 0 (0) |
| Total gambling expenditure (Aus $), n (%) | |||
|
|
Recovered | 3 (13) | 4 (19) |
|
|
Improved | 0 (0) | 0 (0) |
|
|
Unchanged | 19 (86) | 17 (80) |
|
|
Deteriorated | 0 (0) | 0 (0) |
| Craving self-efficacy (11-point VASd), n (%) | |||
|
|
Recovered | 0 (0) | 0 (0) |
|
|
Improved | 4 (18) | 3 (14) |
|
|
Unchanged | 18 (81) | 17 (80) |
|
|
Deteriorated | 0 (0) | 1 (4) |
| Gambling self-efficacy (11-point VAS), n (%) | |||
|
|
Recovered | 0 (0) | 0 (0) |
|
|
Improved | 4 (18) | 3 (14) |
|
|
Unchanged | 18 (81) | 18 (85) |
|
|
Deteriorated | 0 (0) | 0 (0) |
aG-SAS: Gambling-Symptom Assessment Scale.
bRecovered: the final score indicated a reliable change and was in the functional range, indicated by a score of 20 or less on the Gambling-Symptom Assessment Scale or at least a 25% reduction in scores for gambling cravings, total gambling frequency, and total gambling expenditure, and at least a 25% increase in scores for craving self-efficacy and gambling self-efficacy, in postintervention and follow-up evaluations.
cn=20 at 1-month follow-up, as 1 participant did not report gambling frequency.
dVAS: Visual Analogue Scale.